CPHA Canvax
CPHA Canvax

"This report compares vaccination uptake rates for COVID-19 vaccines with those for other vaccine-preventable diseases including influenza, shingles, and pneumococcal disease among older Canadians. Uptake rates for the latter three vaccines are much lower and in the case of influenza and pneumococcal disease, have yet to achieve PHAC’s target vaccination rates of 80% among adults aged 65 years and older. This report also analyzes Canada’s COVID-19 vaccine rollout and identifies five important factors that contributed to the record high rates of vaccination that have been achieved among older Canadians." - Lessons Learned: What Successful COVID-19 Immunization Efforts Taught Us About Improving Vaccine Coverage Among Older Canadians for Other Vaccine-Preventable Diseases


Web link

Lessons Learned: What Successful COVID-19 Immunization Efforts Taught Us About Improving Vaccine Coverage Among Older Canadians for Other Vaccine-Preventable Diseases

Related Resources

Bookmark

Implementation Tool

Link

Category

Vaccination Decision Making,Vaccine Acceptance and Uptake,Understanding Acceptance and Uptake,Monitoring and Surveillance,Vaccine Monitoring and Surveillance,Vaccination Coverage and Goals,Outbreaks and Pandemics,COVID-19,Vaccine Preventable Diseases,Communicable Diseases,Herpes Zoster (Shingles),Influenza,Pneumococcal Disease Vaccination Decision Making
Vaccine Acceptance and Uptake
Understanding Acceptance and Uptake
Monitoring and Surveillance
Vaccine Monitoring and Surveillance
Vaccination Coverage and Goals
Outbreaks and Pandemics
COVID-19
Vaccine Preventable Diseases
Communicable Diseases
Herpes Zoster (Shingles)
Influenza
Pneumococcal Disease

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.